May 3, 2023 Experience Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen We are advising Cellular Biomedicine Group on the transaction
May 3, 2023 Experience Advent International $2.25 billion Maxar Technologies acquisition financing We advised the lenders on the facilities
May 3, 2023 Experience Avaya emerges from chapter 11 We advised the prepetition term loan agent and escrow agent on the transaction
May 3, 2023 Experience Anglo American $900 million notes offering The 5.500% senior notes are due 2033
May 3, 2023 Experience Meta Platforms $8.5 billion senior notes offering We advised Meta on the investment-grade debt offering
May 3, 2023 Experience Invacare chapter 11 plan confirmed We advised the prepetition term loan agent and escrow agent on the transaction
May 1, 2023 Experience Crestview strategic investment in The Gersh Agency We advised Crestview Partners on the transaction
May 1, 2023 Experience Constellation Brands $750 million senior notes offering The investment-grade notes are due 2033
May 1, 2023 Experience JPMorgan acquires assets and assumes certain liabilities of First Republic We advised JPMorgan Chase on the transaction
April 28, 2023 Experience MedSci Healthcare Holdings HK$608 million IPO We advised MedSci on its IPO and HKEX listing